MYGN Operating Cash Flow (Statement)

Myriad Genetics Inc · Operating Cash Flow (Statement)

MYGN logo

MYGN Operating Cash Flow (Statement)

Latest reported$7.70M
MYGN TTM Cash from Operations (-$4.30M → $7.70M)
High-resolution chart · PNG

MYGN operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
7,700,000
2,400,000
1,800,000
-2,200,000
-22,600,000
-6,400,000
-8,700,000
-70,000,000
-92,800,000
-96,300,000
-110,900,000
-63,900,000
-44,600,000
-93,400,000
-106,700,000
-108,900,000
-145,400,000
-100,100,000
18,200,000
13,700,000
-6,300,000
28,100,000
-26,900,000
-14,400,000
60,700,000
62,200,000
52,000,000
91,700,000
83,700,000
100,100,000
105,000,000
100,200,000
115,900,000
104,600,000
134,200,000
132,600,000
106,200,000
126,000,000
130,800,000
151,500,000
184,200,000
178,844,000
162,844,000
163,344,000
140,544,000
130,433,000
111,782,000
106,731,000
190,213,000
212,280,000
238,427,000
212,992,000
173,866,000
152,606,000
155,957,000
161,373,000
141,841,000
136,403,000
123,692,000
133,287,000
130,759,000
140,979,000
155,599,000
161,201,000
155,086,000
147,493,000
112,706,000
111,622,000
84,042,000
156,953,000
153,528,000
112,035,000
103,736,000
-7,850,000
-17,215,000
-24,248,000
-25,851,000
-29,393,000
-31,361,000
-31,378,000
-28,027,000
-23,238,000
-25,037,000
-22,480,000
-23,304,000
-31,290,000
-26,598,000
-28,979,000
-30,880,000
-25,828,000
-39,568,000
-42,156,000
-46,540,000
-40,790,693
-30,310,308
-24,549,043
-16,312,043
-16,791,460
-8,712,505
-8,308,647
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.